Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High-Dose Propranolol

Pediatr Dermatol. 2017 Sep;34(5):e286-e287. doi: 10.1111/pde.13219. Epub 2017 Jul 21.

Abstract

Diffuse hepatic hemangiomas are a challenging disease that can be life threatening. We present the case of an infant with diffuse hepatic hemangiomas who failed first-line therapies but later responded to sirolimus and high-dose propranolol.

Publication types

  • Case Reports

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Hemangioma / drug therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infant, Newborn
  • Liver / pathology
  • Liver Neoplasms / drug therapy*
  • Magnetic Resonance Imaging
  • Male
  • Propranolol / therapeutic use*
  • Sirolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Immunosuppressive Agents
  • Propranolol
  • Sirolimus